210 related articles for article (PubMed ID: 34921636)
1. TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes.
Sun H; Kim E; Ryu J; Lee H; Shin EA; Lee M; Lee H; Lee JH; Yoon JH; Song DG; Kim S; Lee JW
Cell Mol Life Sci; 2021 Dec; 79(1):49. PubMed ID: 34921636
[TBL] [Abstract][Full Text] [Related]
2. Differential TM4SF5-mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression.
Ryu J; Kim E; Kang MK; Song DG; Shin EA; Lee H; Jung JW; Nam SH; Kim JE; Kim HJ; Son T; Kim S; Kim HY; Lee JW
J Pathol; 2021 Jan; 253(1):55-67. PubMed ID: 32918742
[TBL] [Abstract][Full Text] [Related]
3. Blockade of four-transmembrane L6 family member 5 (TM4SF5)-mediated tumorigenicity in hepatocytes by a synthetic chalcone derivative.
Lee SA; Ryu HW; Kim YM; Choi S; Lee MJ; Kwak TK; Kim HJ; Cho M; Park KH; Lee JW
Hepatology; 2009 Apr; 49(4):1316-25. PubMed ID: 19177595
[TBL] [Abstract][Full Text] [Related]
4. Differential inhibition of transmembrane 4 L six family member 5 (TM4SF5)-mediated tumorigenesis by TSAHC and sorafenib.
Lee SA; Lee MS; Ryu HW; Kwak TK; Kim H; Kang M; Jung O; Kim HJ; Park KH; Lee JW
Cancer Biol Ther; 2011 Feb; 11(3):330-6. PubMed ID: 21099346
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.
Ryu J; Kang M; Lee MS; Kim HJ; Nam SH; Song HE; Lee D; Lee JW
Mol Cell Biol; 2014 Aug; 34(16):2946-60. PubMed ID: 24912675
[TBL] [Abstract][Full Text] [Related]
6. Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities.
Kang M; Ryu J; Lee D; Lee MS; Kim HJ; Nam SH; Song HE; Choi J; Lee GH; Kim TY; Lee H; Kim SJ; Ye SK; Kim S; Lee JW
PLoS One; 2014; 9(7):e102817. PubMed ID: 25033048
[TBL] [Abstract][Full Text] [Related]
7. TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes.
Ryu J; Lee JW
Mediators Inflamm; 2017; 2017():5108525. PubMed ID: 28458469
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
9. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
[TBL] [Abstract][Full Text] [Related]
10. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
11. NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.
Sui Q; Zhang J; Sun X; Zhang C; Han Q; Tian Z
J Immunol; 2014 Aug; 193(4):2016-23. PubMed ID: 25015826
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane 4 L six family member 5 (TM4SF5) enhances migration and invasion of hepatocytes for effective metastasis.
Lee SA; Kim TY; Kwak TK; Kim H; Kim S; Lee HJ; Kim SH; Park KH; Kim HJ; Cho M; Lee JW
J Cell Biochem; 2010 Sep; 111(1):59-66. PubMed ID: 20506553
[TBL] [Abstract][Full Text] [Related]
13. MiR-506 Promotes Natural Killer Cell Cytotoxicity against Human Hepatocellular Carcinoma Cells by Targeting STAT3.
Su Z; Ye X; Shang L
Yonsei Med J; 2019 Jan; 60(1):22-29. PubMed ID: 30554487
[TBL] [Abstract][Full Text] [Related]
14. Interaction of tetraspan(in) TM4SF5 with CD44 promotes self-renewal and circulating capacities of hepatocarcinoma cells.
Lee D; Na J; Ryu J; Kim HJ; Nam SH; Kang M; Jung JW; Lee MS; Song HE; Choi J; Lee GH; Kim TY; Chung JK; Park KH; Kim SH; Kim H; Seo H; Kim P; Youn H; Lee JW
Hepatology; 2015 Jun; 61(6):1978-97. PubMed ID: 25627085
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity.
Ahn HM; Ryu J; Song JM; Lee Y; Kim HJ; Ko D; Choi I; Kim SJ; Lee JW; Kim S
Theranostics; 2017; 7(3):594-613. PubMed ID: 28255353
[TBL] [Abstract][Full Text] [Related]
16. CD133-induced TM4SF5 expression promotes sphere growth via recruitment and blocking of protein tyrosine phosphatase receptor type F (PTPRF).
Kim S; Cho CY; Lee D; Song DG; Kim HJ; Jung JW; Kim JE; Park D; Lee H; Um H; Park J; Choi Y; Kim Y; Nam SH; Lee JW
Cancer Lett; 2018 Dec; 438():219-231. PubMed ID: 30217560
[TBL] [Abstract][Full Text] [Related]
17. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
18. The miR-561-5p/CX
Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
[TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis promotes immune escape in hepatocellular carcinoma via GOLM1-mediated PD-L1 upregulation.
Ke MY; Xu T; Fang Y; Ye YP; Li ZJ; Ren FG; Lu SY; Zhang XF; Wu RQ; Lv Y; Dong J
Cancer Lett; 2021 Aug; 513():14-25. PubMed ID: 33992711
[TBL] [Abstract][Full Text] [Related]
20. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]